FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to biotechnology and virology. What is presented is a new strain of parvovirus representing parvovirus-2. The described strain is recovered from a racoon and can be used for immunising dogs against parvovirus infection or damaging tumour cells in a mammal. The presented group of inventions can be used in veterinary science.
EFFECT: there are disclosed vaccine containing this stain, and methods for damaging tumour cells in a mammal and eliciting an immune response in the mammal implying the use of the new strain of parvovirus.
12 cl, 13 dwg, 2 tbl, 6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| VACCINES CONTAINING GENETIC VARIANTS OF CANINE PARVOVIRUS | 2008 |
|
RU2519210C2 |
| ASSOCIATED VACCINE AGAINST CANINE DISTEMPER, PARVOVIRUS AND CORONAVIRUS ENTERITIS, ADENOVIRUS INFECTION OF DOGS | 2022 |
|
RU2806164C1 |
| ASSOCIATED VACCINE AGAINST DISTEMPER, PARVOVIRUS AND CORONAVIRUS ENTERITIS, ADENOVIRUS INFECTION AND CANINE RABIES | 2023 |
|
RU2817255C1 |
| ATTENUATED RECOMBINANT PARVOVIRUS APPLICABLE FOR DOG PROTECTION AGAINST PARVOVIRUS INFECTION | 2011 |
|
RU2527157C2 |
| ARCHIE STRAIN OF VIRUS CARNIVORE PROTOPARVOVIRUS 1 OF PARVOVIRAL ENTERITIS OF DOGS FOR PRODUCING BIOPREPARATIONS FOR DIAGNOSING AND SPECIFIC PREVENTION OF CANINE PARVOVIRUS ENTERITIS | 2023 |
|
RU2817267C1 |
| VACCINES BASED ON VIRUS-LIKE PARTICLES (VLP) OF CANINE PARVOVIRUS (CPV) AND APPLICATION THEREOF | 2016 |
|
RU2710854C1 |
| RECOMBINANT VIRUS EXPRESSING FOREIGN DNA ENCODING FELINE CD80, FELINE CTLA-4 OR FELINE CD86 AND ITS APPLYING | 1999 |
|
RU2244006C2 |
| COMPOSITIONS OF RECOMBINANT CDV AND ITS USE | 2011 |
|
RU2567337C2 |
| VACCINE AGAINST RABIES VIRUS | 2018 |
|
RU2782350C2 |
| CANINE PARVOVIRUS STRAIN R-72 VNIIZZH FOR PREPARING DIAGNOSTIC AND VACCINE PREPARATIONS | 2003 |
|
RU2242994C1 |
